MarketCap
Facebook
X
Telegram
Cutera Accounts Receivables | CUTR
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Cutera
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.1 M | 45.6 M | 31.4 M | 22 M | 21.6 M | 19.6 M | 20.8 M | 16.5 M | 11.7 M | 11.1 M | 9.68 M | 8.84 M | 5.19 M | 4.21 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 45.6 M | 4.21 M | 19.4 M |
Quarterly Accounts Receivables Cutera
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.2 M | 34.6 M | 37 M | 43.1 M | 49.8 M | 53.7 M | 51.7 M | 45.6 M | 35.9 M | 32.1 M | 33.2 M | 31.4 M | 30.8 M | 25.9 M | 24.2 M | 22 M | 17.6 M | 13.8 M | 15.7 M | 21.6 M | 23.2 M | 24.9 M | 19.1 M | 19.6 M | 25.4 M | 22.1 M | 19.9 M | 20.8 M | 19.6 M | 18.2 M | 17.9 M | 16.5 M | 11.7 M | 11.2 M | 11.2 M | 11.7 M | 9.01 M | 8.92 M | 10.4 M | 11.1 M | 8.74 M | 7.6 M | 6.59 M | 9.68 M | 7.49 M | 7.54 M | 6.81 M | 8.84 M | 7.84 M | 6.2 M | 4.5 M | 5.19 M | 4.08 M | 3.28 M | 5.19 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 53.7 M | 3.28 M | 19.7 M |
Accounts Receivables of other stocks in the Medical devices industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Conformis
CFMS
|
9.77 M | - | - | $ 16.4 M |  USA |
 |
Bruker Corporation
BRKR
|
545 M | $ 64.0 | 7.26 % | $ 9.72 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
123 M | $ 8.7 | 0.06 % | $ 634 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
6.55 M | $ 14.61 | 13.03 % | $ 414 M | USA |
 |
CONMED Corporation
CNMD
|
248 M | $ 45.18 | 3.31 % | $ 1.4 B | USA |
 |
Cytosorbents Corporation
CTSO
|
7.55 M | $ 4.3 | 1.63 % | $ 268 M | USA |
 |
Eargo
EAR
|
1.91 M | - | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
11.7 M | $ 16.08 | 0.75 % | $ 576 M | USA |
 |
Electromed
ELMD
|
29.8 M | $ 27.86 | 1.05 % | $ 230 M | USA |
 |
Establishment Labs Holdings
ESTA
|
77.5 M | $ 65.58 | 3.69 % | $ 1.94 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
660 M | $ 85.73 | 0.32 % | $ 50.1 B | USA |
 |
AdaptHealth Corp.
AHCO
|
371 M | $ 5.57 | 0.43 % | $ 753 M | USA |
 |
Helius Medical Technologies
HSDT
|
70 K | $ 2.9 | 0.69 % | $ 63.9 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
279 M | $ 15.88 | 2.25 % | $ 1.22 B | USA |
 |
Inogen
INGN
|
38.9 M | $ 5.23 | 2.75 % | $ 139 M | USA |
 |
InMode Ltd.
INMD
|
43.5 M | $ 14.19 | 0.21 % | $ 917 M | Israel |
 |
Inspire Medical Systems
INSP
|
120 M | $ 68.81 | 0.59 % | $ 2.02 B | USA |
 |
IRIDEX Corporation
IRIX
|
7.61 M | $ 0.63 | 2.51 % | $ 10.7 M | USA |
 |
IRadimed Corporation
IRMD
|
13.7 M | $ 85.2 | 0.08 % | $ 1.08 B | USA |
 |
AxoGen
AXGN
|
26.2 M | $ 43.32 | 0.48 % | $ 1.99 B | USA |
 |
Align Technology
ALGN
|
1.1 B | $ 145.63 | 4.36 % | $ 10.6 B | USA |
|
LENSAR
LNSR
|
6.38 M | $ 7.08 | 0.28 % | $ 84.7 M | USA |
 |
Sientra
SIEN
|
36.9 M | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
23.6 M | - | - | $ 1.07 B | USA |
 |
Medtronic PLC
MDT
|
6.64 B | $ 88.51 | 0.32 % | $ 113 B | USA |
 |
MiMedx Group
MDXG
|
75.7 M | $ 4.71 | 0.1 % | $ 696 M | USA |
 |
Surgalign Holdings
SRGA
|
16.1 M | - | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
115 M | - | - | $ 12.3 B | USA |
 |
Myomo
MYO
|
4.1 M | $ 1.67 | 1.83 % | $ 69.9 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
367 K | $ 0.66 | 0.45 % | $ 42.8 M | Israel |
 |
InspireMD
NSPR
|
2.17 M | $ 0.7 | 0.37 % | $ 45 M | Israel |
 |
Orthofix Medical
OFIX
|
136 M | $ 9.16 | 0.11 % | $ 363 M |  Curacao |
 |
Outset Medical
OM
|
28.3 M | $ 3.13 | 1.29 % | $ 47.6 K | USA |
 |
Insulet Corporation
PODD
|
141 M | $ 135.78 | 0.01 % | $ 9.55 B | USA |
 |
Profound Medical Corp.
PROF
|
7.2 M | $ 5.6 | 1.66 % | $ 169 M |  Canada |
 |
Quanterix Corporation
QTRX
|
30 M | $ 3.18 | 0.63 % | $ 136 M | USA |
 |
Natus Medical Incorporated
NTUS
|
112 M | - | 1.94 % | $ 1.05 B | USA |
 |
AVITA Medical
RCEL
|
9.09 M | $ 11.58 | 5.75 % | $ 323 M |  Australia |
 |
Cardiovascular Systems
CSII
|
39.7 M | - | 0.15 % | $ 844 M | USA |
 |
Apyx Medical Corporation
APYX
|
16.8 M | $ 2.83 | 1.37 % | $ 116 M | USA |
 |
Sintx Technologies
SINT
|
178 K | $ 1.87 | 5.06 % | $ 5.19 M | USA |
 |
Accuray Incorporated
ARAY
|
67.4 M | $ 0.22 | 0.4 % | $ 27 M | USA |
 |
Inari Medical
NARI
|
70.1 M | - | - | $ 4.23 B | USA |